1 / 9

HIT Policy Committee

HIT Policy Committee. Quality Workgroup September 14, 2010. QM Workgroup Members. David Blumenthal, MD (Chair) David Lansky (Co-Chair)

kiona
Download Presentation

HIT Policy Committee

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIT Policy Committee Quality Workgroup September 14, 2010

  2. QM Workgroup Members • David Blumenthal, MD (Chair) • David Lansky (Co-Chair) • Peter Basch, Christine Bechtel, Eva Powell, Tripp Bradd, Russ Branzell, Helen Burstin, Neil Calman, Frances Cotter, Terry Cullen, Carol Diamond, Timothy Ferris, Steve Fong, Kate Goodrich, Patrick Gordon, Daniel Green, Charles Kennedy, David Kendrick, Karen Kmetik, Bob Kocher, Paul Tang, Marc Overhage, Laura Petersen, Jacob Reider, Sarah Scholle, Cary Sennett, Jesse Singer, Steve Solomon, Kalahn Taylor-Clark, James Walker, Jon White, and Paul Wallace

  3. Current State • Stage 1 Meaningful Use contains 44 PRQI measures and 15 RHQDAPU Clinical Measures that have been retooled with electronic specifications. • Currently, measure development does not take advantage of robust clinical health information from EHRs. • A need to develop measures that are parsimonious, HIT sensitive, enable longitudinal measurement, across various settings of care, improve population health and reduce burden of care.

  4. Charge to QM Workgroup • To provide recommendations on clinical quality measures for Stage 2 and Stage 3, with a focus on meaningful use of certified EHR technology. The measures are meant to be appropriate and applicable to a broad range of providers. Each measure should use data that can be feasibly collected within the EHR.

  5. Objectives of QM Workgroup • Identify priority domains and gaps for electronic Quality Measure development for Stage 2 Meaningful Use. • Identify key priority measure concepts within each domain. • Address methodologic issues such as incorporation of patient data, “delta measures” through the use of Tiger Teams.

  6. Objectives (cont.) • Provide guidance on Request for Information (RFI) for measure developers to identify potential Stage 2 eQMs based on preliminary recommendations from the QM Workgroup.

  7. Measure Attributes • HIT sensitive • parsimonious • enables longitudinal measurement • enables measurement across settings of care • improve population health and reduce burden of illness

  8. Preliminary Measure Domains • Patient and Family Engagement • Population Health/Public Health • Safety • Care Coordination • Overuse/Underuse/Appropriate Care • Disparities • Patient-Focused Episodes of Care

  9. Methodologic Issues • Move towards interoperability • Incorporate patient-reported information • Incorporate risk adjustment • “Delta” measures

More Related